| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/14737167.2017.1277143 |
| P698 | PubMed publication ID | 28043174 |
| P50 | author | Thomas Trikalinos | Q60056375 |
| P2093 | author name string | Issa J Dahabreh | |
| John B Wong | |||
| P2860 | cites work | Coronary heart disease policy models: a systematic review | Q28200183 |
| Calibration methods used in cancer simulation models and suggested reporting guidelines | Q28749665 | ||
| Pseudo Maximum Likelihood Methods: Theory | Q29391634 | ||
| Teleoanalysis: combining data from different types of study | Q30824952 | ||
| Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma | Q30979196 | ||
| Estimation of markov chain transition probabilities and rates from fully and partially observed data: uncertainty propagation, evidence synthesis, and model calibration | Q31017619 | ||
| Confronting models with data | Q31114314 | ||
| Bayesian Calibration of Microsimulation Models | Q33588068 | ||
| Calibration of disease simulation model using an engineering approach | Q33926840 | ||
| Testing the validity of cost-effectiveness models | Q34025545 | ||
| Effect of screening and adjuvant therapy on mortality from breast cancer | Q34463105 | ||
| Individual-based simulation models of HIV transmission: reporting quality and recommendations. | Q35010032 | ||
| Systematic assessment of decision models in Parkinson's disease. | Q35887508 | ||
| Generalisability in economic evaluation studies in healthcare: a review and case studies. | Q35950554 | ||
| Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening | Q36340374 | ||
| The generalisability of pharmacoeconomic studies: issues and challenges ahead | Q36604292 | ||
| Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK | Q36610489 | ||
| Plausible and implausible parameters for mathematical modeling of nominal heterosexual HIV transmission | Q36744601 | ||
| Calibration of complex models through Bayesian evidence synthesis: a demonstration and tutorial | Q36843345 | ||
| A review and critique of modelling in prioritising and designing screening programmes. | Q37010504 | ||
| Obstructive lung disease models: what is valid? | Q37437429 | ||
| Model-based cost-effectiveness analyses for the treatment of acute stroke events: a review and summary of challenges | Q37629906 | ||
| Decision-analytic models to simulate health outcomes and costs in heart failure: a systematic review | Q37873923 | ||
| Mathematical models for the study of HIV spread and control amongst men who have sex with men. | Q37935620 | ||
| Modelling the cost effectiveness of treatments for Parkinson's disease: a methodological review | Q37955238 | ||
| Economic evaluation of smoking-cessation therapies: a critical and systematic review of simulation models | Q38010473 | ||
| Systematic assessment of decision-analytic models for chronic myeloid leukemia. | Q38175353 | ||
| Recommendations for the Conduct and Reporting of Modeling and Simulation Studies in Health Technology Assessment | Q38983054 | ||
| Calibrating models in economic evaluation: a seven-step approach. | Q39553763 | ||
| Methods of model calibration: observations from a mathematical model of cervical cancer | Q39828995 | ||
| Multiparameter evidence synthesis in epidemiology and medical decision-making | Q40028428 | ||
| Methods for Building and Validating Equations for Physiology-Based Mathematical Models: Glucose Metabolism and Type 2 Diabetes in the Archimedes Model. | Q40454962 | ||
| An introduction to a Bayesian method for meta-analysis: The confidence profile method | Q43535955 | ||
| A Bayesian method for synthesizing evidence. The Confidence Profile Method | Q43559805 | ||
| Archimedes: a trial-validated model of diabetes | Q44631774 | ||
| Calibrating models in economic evaluation: a comparison of alternative measures of goodness of fit, parameter search strategies and convergence criteria | Q45309251 | ||
| Estimating treatment effect via simple cross design synthesis. | Q46002999 | ||
| Validation of the Archimedes Diabetes Model | Q46068078 | ||
| Validation of a decision model for preventive pharmacological strategies in postmenopausal women | Q46366785 | ||
| Incorporating calibrated model parameters into sensitivity analyses: deterministic and probabilistic approaches | Q46659871 | ||
| Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling | Q47345641 | ||
| Goodness-of-fit measures for individual-level models of infectious disease in a Bayesian framework | Q47432870 | ||
| Approximate cross‐validatory predictive checks in disease mapping models | Q47945903 | ||
| Validation of economic and health outcomes simulation model of type 2 diabetes mellitus (ECHO-T2DM). | Q51211134 | ||
| Bayesian calibration of a natural history model with application to a population model for colorectal cancer. | Q51628329 | ||
| Latent class model diagnosis. | Q51971187 | ||
| Markov chain Monte Carlo estimation of a multiparameter decision model: consistency of evidence and the accurate assessment of uncertainty. | Q52035592 | ||
| The confidence profile method: a Bayesian method for assessing health technologies. | Q52539205 | ||
| A new form of meta-analysis for combining results from randomized clinical trials and medical-practice databases. | Q52885014 | ||
| Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7. | Q53123530 | ||
| Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective. | Q53186086 | ||
| Evaluating the use of “goodness-of-fit” Measures in hydrologic and hydroclimatic model validation | Q57258580 | ||
| Convex Optimization | Q58633368 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | model calibration | Q95753510 |
| P304 | page(s) | 27-37 | |
| P577 | publication date | 2017-01-03 | |
| P1433 | published in | Expert Review of Pharmacoeconomics & Outcomes Research | Q15734522 |
| P1476 | title | Validation and calibration of structural models that combine information from multiple sources | |
| P478 | volume | 17 |
Search more.